Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Roll Call
Fireworks Fly
Op-Eds
Recent Research Suggests…
There has been a great deal of ballyhoo this week over the decision by the U.S. Food and Drug Administration to require food products…
News Release
Pharmaceutical Re-Imports Threaten Medical Innovation
Contact for Interviews: Richard Morrison, 202.331.2273 Washington, D.C., July 18, 2003—The Competitive Enterprise Institute is opposing proposals to allow the re-importation of drugs from foreign…
Op-Eds
Rules May Save Fuel but Won’t Save Lives
When it comes to saving fuel, federal Corporate Average Fuel Economy (CAFE) regulations are expensive, cumbersome and insidiously deadly. They force new technologies…
News Release
New! CEI’s Politically Correct Periodic Table Mousepad
Preview of the mousepad available in pdf format. Learn the “new” chemistry from this mousepad guide to…
Op-Eds
Biotech Woes…and the Culprits
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />America learned long ago that what's good for General Motors isn't necessarily good for the country.